drugset
drugset / Trial / NCT04647435

Efficacy and Safety of APSCTC for the Treatment of Postsurgical Pain Due to Third Molar Extraction

NCT04647435 ↗

Phase 3 Completed 396 enrolled Apsen Farmaceutica S.A.
RandomizedParallel-groupDouble-blindTreatment

Summary

The purpose of this study is to evaluate the efficacy of APSCTC compared to two active drugs in acute pain relief.

Timeline

Start
2023-05-13
Primary completion
2024-10-04
Completion
2024-10-04

Drugs

EvaluationDrugModalityDoseRoute
Subject APSCTC Unknown — Oral
Comparator Toragesic® Unknown — Oral
Comparator Tramadol Other / unclassified — Oral

Indications

No indication recorded.